Niraparib and Dostarlimab in HRD Solid Tumors
Clinical trial NCT04983745 · UNKNOWN
Trial details
- NCT number
- NCT04983745
- Sponsor
- West Cancer Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-29
- Primary completion
- 2024-08-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.